Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference74 articles.
1. A Tumor Suppressing Duo: TGFβ and Activin Modulate a Similar Transcriptome
2. The tor pathway: a target for cancer therapy
3. Mammalian target of rapamycin inhibition as therapy for hematologic malignancies
4. mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery
5. GβL, a Positive Regulator of the Rapamycin-Sensitive Pathway Required for the Nutrient-Sensitive Interaction between Raptor and mTOR
Cited by 96 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions;Pharmacology Biochemistry and Behavior;2023-02
2. Recent advances and limitations of mTOR inhibitors in the treatment of cancer;Cancer Cell International;2022-09-15
3. Sex differences in cancer risk and outcomes after kidney transplantation;Transplantation Reviews;2021-07
4. Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study;ESMO Open;2021-04
5. Human Positive Coactivator 4 Affects the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma via the mTOR/P70s6k Signaling Pathway;OncoTargets and Therapy;2020-11
Human Positive Coactivator 4 Affects the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma via the mTOR/P70s6k Signaling Pathway
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3